Global Adoption of High-Sensitivity Cardiac Troponins and the Universal Definition of Myocardial Infarction
Global Adoption of High-Sensitivity Cardiac Troponins and the Universal Definition of Myocardial Infarction
复制标题
DOI:
10.1373/clinchem.2018.298059
复制
发表时间:
2019-03-01
影响因子:
9.3
通讯作者:
Mills, Nicholas L.
中科院分区:
文献类型:
--
作者:
Anand, Atul;Shah, Anoop S., V;Mills, Nicholas L.
BACKGROUND: The universal definition of myocardial infarction (UDMI) standardizes the approach to the diagnosis and management of myocardial infarction. High-sensitivity cardiac troponin testing is recommended because these assays have improved precision at low concentrations, but concerns over specificity may have limited their implementation.METHODS: We undertook a global survey of 1902 medical centers in 23 countries evenly distributed across 5 continents to assess adoption of key recommendations from the UDMI. Respondents involved in the diagnosis and management of patients with suspected acute coronary syndrome completed a structured telephone questionnaire detailing the primary biomarker, diagnostic thresholds, and clinical pathways used to identify myocardial infarction.RESULTS: Cardiac troponin was the primary diagnostic biomarker at 96% of surveyed sites. Only 41% of centers had adopted high-sensitivity assays, with wide variation from 7% in North America to 60% in Europe. Sites using high-sensitivity troponin more frequently used serial sampling pathways (91% vs 78%) and the 99th percentile diagnostic threshold (74% vs 66%) than sites using previous-generation assays. Furthermore, highsensitivity institutions more often used earlier serial sampling (